EndoQuest Robotics Funding
Overview
Products
Funding
Investors
Context
Discovery
Relations
Timeline
Funding
2025-07-14 - Series D-2 - $30.7M - EndoQuest Robotics closes Series D-2; filing reports $30.745 million sold
- EndoQuest Robotics closed a Series D-2 financing co-led by Crescent Enterprises and Dr. Fred Moll to advance its pivotal clinical trial, FDA pathway and endoluminal visualization systems. - source: globenewswire.com
2023-12-04 - C-1 - $42M - EndoQuest raises $42M C-1 financing for endoluminal robotics
- EndoQuest Robotics closed a $42 million C-1 financing to advance its flexible endoluminal robotic surgery platform. - source: endoquestrobotics.com
View EndoQuest Robotics overview